Now showing items 1-2 of 2
Interchangeability of low-dose oral contraceptives : Are current bioequivalent testing measures adequate to ensure therapeutic equivalency?
(Elsevier, 1991-02)
Current Food and Drug Administration guidelines for assessing the differences in bioavailability between generic oral contraceptives and brand-name products are inadequate to ensure therapeutic equivalence. The guidelines ...